Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

Operating Cash Flow (Statement)

$411.00M

Quarterly · Period ending: · USD

TEVA logo

TEVA Operating Cash Flow (Statement)

Latest reported$411.00M
TEVA Quarterly Cash from Operations ($86.97M → $411.00M)
High-resolution chart · PNG

TEVA operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
411,000,000
-40,000,000
1,158,000,000
369,000,000
227,000,000
-105,000,000
575,000,000
693,000,000
103,000,000
-124,000,000
1,184,000,000
5,000,000
324,000,000
-145,000,000
973,000,000
543,000,000
123,000,000
-49,000,000
456,000,000
529,000,000
218,000,000
-405,000,000
331,000,000
307,000,000
273,000,000
305,000,000
538,000,000
325,000,000
-227,000,000
112,000,000
367,000,000
421,000,000
162,000,000
1,496,000,000
1,179,000,000
1,117,000,000
741,000,000
470,000,000
1,425,000,000
1,461,000,000
963,000,000
1,376,000,000
1,615,000,000
1,093,000,000
1,480,000,000
1,354,000,000
1,752,000,000
1,424,000,000
1,053,000,000
898,000,000
816,000,000
444,000,000
875,000,000
1,102,000,000
1,577,000,000
1,048,000,000
1,191,000,000
756,000,000
1,428,000,000
482,000,000
1,324,000,000
900,000,000
1,102,000,000
1,194,000,000
954,000,000
886,000,000
957,000,000
1,025,000,000
658,000,000
733,000,000
969,000,000
710,000,000
806,000,000
746,000,000
545,000,000
332,000,000
437,000,000
499,000,000
764,400,000
792,800,000
212,300,000
288,500,000
259,100,000
385,300,000
422,900,000
302,700,000
386,900,000
391,400,000
246,800,000
223,700,000
186,500,000
138,400,000
98,100,000
203,600,000
28,300,000
92,400,000
130,000,000
103,000,000
50,348,000
66,116,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.